0001209191-22-016527.txt : 20220304
0001209191-22-016527.hdr.sgml : 20220304
20220304205845
ACCESSION NUMBER: 0001209191-22-016527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220302
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wassil Jim
CENTRAL INDEX KEY: 0001813798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39323
FILM NUMBER: 22716016
MAIL ADDRESS:
STREET 1: C/O VAXCYTE, INC.
STREET 2: 353 HATCH DRIVE
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxcyte, Inc.
CENTRAL INDEX KEY: 0001649094
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 464233385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-837-0111
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD, STE. 300
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: SutroVax, Inc.
DATE OF NAME CHANGE: 20150724
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-02
0
0001649094
Vaxcyte, Inc.
PCVX
0001813798
Wassil Jim
C/O VAXCYTE, INC.
825 INDUSTRIAL ROAD, STE. 300
SAN CARLOS
CA
94070
0
1
0
0
Chief Operating Officer
Common Stock
2022-03-02
4
A
0
25000
0.00
A
42944
D
Stock Option (right to buy)
24.79
2022-03-02
4
A
0
100000
0.00
A
2032-03-01
Common Stock
100000
100000
D
Stock Option (right to buy)
24.79
2022-03-02
4
A
0
150000
0.00
A
2032-03-01
Common Stock
150000
150000
D
Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
12/48 of shares subject to the option vest on February 15, 2023, and 1/48 of the shares vest monthly thereafter.
1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.
/s/ Ron Metzger, Attorney-in-Fact
2022-03-04